How to Get GLP-1 Patients as a Psychiatrist in New York

If you’re a psychiatrist watching the GLP-1 boom and wondering whether there’s a place for you in weight management — the answer is a resounding yes. And not just because the market is exploding (though it is). It’s because you bring something most weight-loss clinics can’t: expertise in behavior change, mental health, and the complex interplay between psychiatric medications and metabolism.

Here’s the reality: By 2025, an estimated 6% of Americans (20 million people) were taking GLP-1 medications like Ozempic or Wegovy — a staggering 600% increase in weight-loss usage over just six years. Demand is outpacing supply, especially for providers who can offer more than just a prescription. Patients need support navigating side effects, managing the psychological aspects of weight loss, and staying motivated through plateaus.

The opportunity is real. But so is the risk of burnout if you don’t build this practice the right way.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

Let’s start with what you already know that most providers don’t: weight and mental health are inseparable.

Your Existing Patient Base Needs This

Many of your current psychiatric patients are already struggling with weight — often as a direct result of the medications you’ve prescribed. Antipsychotics, mood stabilizers, and some antidepressants cause significant weight gain. A late-2023 survey across major psychiatric departments found that nearly half of psychiatrists were already prescribing or recommending Ozempic or similar drugs to address this exact issue.

You’re not starting from zero. You have patients who would benefit right now.

You Understand Behavior Change

Unlike a quick-script telehealth mill, you know that sustainable weight loss requires more than medication. It requires addressing emotional eating, building new habits, managing expectations, and supporting patients through setbacks. Your training in motivational interviewing, cognitive-behavioral techniques, and long-term patient relationships gives you a massive advantage.

Some emerging research even suggests GLP-1s might independently improve certain psychiatric symptoms in conditions like depression and bipolar disorder — though more data is needed. What’s clear is that when patients lose weight and regain confidence, their mental health often improves. You’re positioned to monitor both sides of that equation.

The Business Case Is Strong

Obesity affects roughly 75% of Americans, yet there’s a severe shortage of obesity medicine specialists. Tens of thousands of new patients start GLP-1 treatments every week, and many can’t access specialized care. This isn’t a saturated market — it’s wide open, especially in telehealth where you can reach underserved areas.

And unlike insurance-dependent psychiatric care, much of GLP-1 practice operates on cash-pay models (more on that below). This means predictable revenue, no prior authorizations for visits, and patients who are highly motivated because they’re paying out-of-pocket.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Getting GLP-1 Patients: Internal Conversion vs. External Marketing

You have two paths to building patient volume: starting with your existing caseload or attracting new patients specifically for weight management.

Start With Who You Already Know

The fastest, lowest-risk way to start is identifying current patients who meet criteria:

• BMI ≥30, or
• BMI ≥27 with weight-related comorbidities (hypertension, diabetes, sleep apnea)
• Patients experiencing medication-induced weight gain

During your next medication review, bring it up: ‘I know you’ve been frustrated about the weight gain from your mood stabilizer. I’ve started offering medical weight management with medications like semaglutide. Would you like to discuss whether that might help?’

Many patients will jump at this. They’ve been hoping you’d address it. This approach requires zero marketing budget and leverages trust you’ve already built.

Attracting New Patients: Platforms vs. DIY Marketing

For growth beyond your current panel, you’ll need to bring in new patients seeking weight-loss care.

Telehealth Platforms (The Smart ROI Play):

The most efficient route is joining a telehealth platform that already has patient acquisition infrastructure. Companies like Klarity Health specialize in matching patients with prescribers for GLP-1 services. Here’s why this works:

• Pre-qualified patients: These platforms invest heavily in marketing and funnel patients who are already interested, have done their research, and are ready to book. You’re not wasting time on tire-kickers.
• Pay-per-appointment model: Instead of gambling $3,000-5,000/month on Google Ads or SEO with uncertain results, you pay a standard listing fee only when a qualified patient books with you. That’s guaranteed ROI.
• Built-in telehealth infrastructure: EMR integration, video visits, e-prescribing, billing support — all handled. No separate platform costs.
• Both insurance and cash-pay flow: Platforms serve diverse patient populations, giving you flexibility in how you structure your practice.
• You control your schedule: Set your availability, cap new patients when you need to, scale up when you’re ready.

Think of it this way: acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ when you factor in ALL costs — agency fees, ad spend testing, staff time handling leads, no-show rates, and failed campaigns. SEO takes 6-12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.

A platform model removes that risk entirely. You pay only for results.

DIY Marketing (If You Have Time and Budget):

If you prefer to build your own brand and patient acquisition, you can:

• SEO: Create content on your website about ‘psychiatrist weight loss specialist,’ ‘GLP-1 for medication weight gain,’ etc. This takes months to gain traction but can eventually drive organic traffic.
• Google Ads: Mental health keywords are expensive ($15-40+ per click), and most clicks don’t convert. Realistic cost per booked patient through PPC is $200-400+.
• Social Media: Share patient success stories (with consent), educate about the mental health benefits of weight loss, position yourself as the provider who treats the whole person.
• Directory Listings: Psychology Today, Zocdoc, and specialty obesity directories. These charge monthly fees ($100-300+) and you compete with hundreds of providers on the same page. Zocdoc also charges per booking ($35-100).

DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling — a platform that handles acquisition is the smarter play.

Referral Networks

Don’t overlook the power of referrals from:

• Primary care physicians who are overwhelmed with weight-loss requests
• Endocrinologists managing diabetic patients who also need obesity care
• Therapists and dietitians whose clients need medication support

Send brief emails introducing your service. Emphasize you’ll provide updates and refer patients back for routine care. Mental health professionals especially appreciate psychiatrists who can address the medication side while they handle counseling.

Cash-Pay vs. Insurance: Understanding the Economics

Most GLP-1 weight-loss practices favor cash-pay models, and here’s why:

The Insurance Reality

While most insurers cover GLP-1 drugs for diabetes, coverage for obesity is extremely limited. As of mid-2024, only 13 state Medicaid programs (including California, Pennsylvania, and Illinois) covered GLP-1s for weight loss. Many private plans explicitly exclude them.

This means even if you accept insurance for visits, patients often pay out-of-pocket for medications anyway. Brand-name Wegovy can cost $1,300+ per month without coverage. Compounded semaglutide from specialty pharmacies runs a few hundred dollars.

Patients know this. They’re already prepared to pay.

Cash-Pay Advantages

• Simpler operations: No credentialing, prior authorizations, claim denials, or billing headaches
• Direct revenue: Patients pay for consults (per visit or monthly subscription) and medications upfront
• Higher margins: You can charge what your expertise is worth — typically $150-300 for initial consults, $75-150 for follow-ups
• Better patient commitment: When people pay out-of-pocket, they tend to be more engaged and compliant

Insurance Participation

If you want to accept insurance to widen access:

• Bill standard E/M codes for obesity counseling/management
• Use Medicare G0447 code for behavioral counseling for obesity (if applicable)
• Be prepared for extensive documentation requirements
• Expect lower reimbursement rates
• Coordinate with pharmacies on medication prior authorizations (which often get denied anyway)

The Hybrid Approach

Many providers do both:

• Charge cash for the initial comprehensive evaluation (which insurance rarely reimburses adequately)
• Accept insurance for follow-up visits if the patient has good coverage
• Always make clear what’s cash-pay vs. billed, and help patients estimate monthly medication costs

Transparency is key. When patients understand the total cost upfront and see the value, they’re less likely to churn.

Telehealth Compliance: Prescribing GLP-1s Across State Lines

Here’s the good news: GLP-1 medications are not controlled substances. This means the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can legally prescribe semaglutide via telehealth without ever meeting the patient face-to-face — as long as you’re licensed in their state and meet the standard of care.

Licensure Requirements

You must be licensed in the patient’s state. Period. This applies whether you’re seeing them via video from across the country or down the street.

Psychiatrists (MD/DO):

• Full prescriptive authority in all states
• Many states are part of the Interstate Medical Licensure Compact (IMLC), which expedites multi-state licensing (Texas, Florida, Pennsylvania, Illinois are members; California and New York are not)
• Some states (like Florida) offer out-of-state telehealth provider registration for physicians — a lighter alternative to full licensure

Psychiatric Nurse Practitioners (PMHNPs):

• Scope of practice varies significantly by state
• Most states require physician collaboration agreements for prescribing
• A few states grant full practice authority after meeting experience requirements (New York: 3,600 hours; California: 3 years supervised, then independent starting 2026; Illinois: 4,000 hours + 250 hours education)
• Texas, Pennsylvania, and most of Florida require ongoing physician supervision — no independent practice for psych NPs

If you’re an NP planning to offer GLP-1 services in a collaborative state, you’ll need a supervising physician on board (many platforms provide this).

Standard of Care

Conduct a thorough video evaluation just as you would in-person:

• Comprehensive medical history (prior weight-loss attempts, comorbidities, medications, contraindications)
• Mental health screening (depression, eating disorders, suicide risk)
• Baseline labs (A1c, fasting glucose, thyroid, liver enzymes — these can be ordered to a local lab)
• Informed consent about off-label use (if prescribing Ozempic instead of Wegovy), side effects, lifestyle requirements

Document everything meticulously. If you wouldn’t feel comfortable defending it in a chart review, don’t do it.

State-Specific Telehealth Rules

Most states have updated telehealth regulations post-COVID, and none prohibit GLP-1 prescribing specifically. However, nuances exist:

• California: Requires documenting patient consent for telehealth (verbal or written)
• Texas: Allows establishing the patient-provider relationship entirely via video; no in-person visit required
• Florida: Similar standard; video evaluation sufficient if it meets standard of care
• New York, Pennsylvania, Illinois: No special barriers — just follow standard telemedicine practice

Audio-only visits are generally not acceptable for initial GLP-1 evaluations (you need to see the patient), but some states allow audio-only for mental health follow-ups.

A Note on Compounded Medications

Many telehealth obesity practices use compounded semaglutide to offer lower-cost options. This is legal, but:

• Ensure your compounding pharmacy is properly licensed and FDA-compliant
• The FDA has issued warnings about unregulated compounders selling questionable products
• If in doubt, stick to FDA-approved medications (Wegovy, Saxenda, Zepbound) or vet your pharmacy carefully

Your malpractice insurer should be informed that you’re prescribing weight-loss medications. Most will have no issue (obesity is a recognized chronic disease), but it’s prudent to confirm coverage.

Scaling Without Burnout: Building Sustainable Workflows

The allure of high patient demand can quickly turn into overwhelm if you don’t build smart systems. Here’s how to scale a GLP-1 practice without sacrificing your sanity.

Streamline Your Intake

Create a digital intake process that gathers comprehensive information before the first visit:

• Weight history, diet and exercise habits, previous weight-loss attempts
• Full medical history, current medications, allergies
• Mental health screening (PHQ-9, GAD-7, eating disorder screen)
• Labs (order a standard ‘Obesity Intake Panel’ with one click: A1c, TSH, CMP, lipid panel)

Use forms, questionnaires, and automated systems to collect this data. It saves 10-15 minutes per visit and ensures nothing is missed.

Standardize Your Protocols

Develop clinical protocols for:

• Inclusion/exclusion criteria (BMI thresholds, contraindications, when to refer out)
• Dose titration schedules (e.g., start semaglutide at 0.25mg weekly, increase by 0.25mg every 4 weeks up to target)
• Managing common side effects (nausea, constipation, fatigue)
• Monitoring schedules (monthly visits for first 3-6 months, then every 2-3 months once stable)

Template notes in your EMR for routine follow-ups. A stable patient on semaglutide 1mg might only need a 15-minute check-in to review weight, side effects, and lifestyle progress.

Delegate Non-Specialist Tasks

You don’t need to do everything:

• Medical assistants or RNs can gather interim data (weights, blood pressure, symptom questionnaires) before visits
• Health coaches or dietitians can handle lifestyle counseling, meal planning, exercise support
• Group telehealth sessions led by staff can provide education and motivation to multiple patients at once (weekly 30-minute Zoom for nutrition tips, Q&A)

This frees you to focus on medication management and complex cases where your psychiatric expertise adds unique value.

Leverage Technology

• Automated appointment reminders reduce no-shows
• Online scheduling eliminates phone tag
• Patient portals for secure messaging, lab results, educational resources
• Remote monitoring (connected scales, apps for tracking weight and adherence) — you can review trends at a glance rather than collecting data live
• AI chatbots for FAQs (‘Is nausea normal?’ ‘What if I miss a dose?’)

Technology isn’t about replacing human care; it’s about removing friction so you can spend your time on what matters.

Set Boundaries Early

• Cap daily consults when starting out (e.g., 2-3 GLP-1 patients per day until you refine workflows)
• Block admin time weekly for reviewing labs, handling messages, updating protocols
• Set firm availability hours for patient communication (e.g., portal messages answered within 24 hours Mon-Fri, no weekends)
• Use delayed send or an answering service after hours to protect personal time

Telehealth’s flexibility can blur work-life boundaries. Protect your time proactively.

Monitor Your Own Well-Being

Watch for burnout signs:

• Emotional exhaustion
• Cynicism about patients
• Declining work quality
• Physical symptoms (insomnia, headaches, GI issues)

If you notice these, reassess your workload immediately. Options include:

• Temporarily capping new patient intakes
• Hiring a part-time NP or PA to share the load (if you’re an MD supervising)
• Delegating more tasks to support staff
• Taking a scheduled week off

Remember: scaling should be gradual. Start with a manageable patient panel, optimize your systems, then grow. Rushing leads to chaos.

The ROI of Doing This Right

Let’s talk numbers. A well-run GLP-1 practice can generate significant revenue:

• Initial consult: $150-300 cash-pay (60 minutes)
• Follow-up visits: $75-150 cash-pay (15-30 minutes)
• Monthly subscription models: Some providers charge $199-299/month all-inclusive (visits + medication)
• Patient volume: A psychiatrist seeing 10-15 GLP-1 patients per week (mix of new and follow-ups) can add $5,000-10,000/month in revenue

Compare that to traditional insurance-based psychiatry, where reimbursement rates are often $100-150 for a 30-minute med check — and you spend hours on prior authorizations.

The economics are compelling. But only if you build it sustainably.

Final Thoughts: You’re Not Just Prescribing Weight-Loss Drugs

Here’s what sets you apart from the telehealth mills flooding the market: You actually care about the whole person.

You understand that weight loss isn’t just about a number on a scale. It’s about self-image, relationships, mental health, and long-term behavior change. You can spot when a patient’s depression is sabotaging their progress. You can adjust their antipsychotic to reduce weight gain while offering GLP-1 support. You can screen for eating disorders that others might miss.

That’s your competitive advantage. Lean into it.

Join a platform like Klarity Health that connects you with patients who need exactly what you offer. Build efficient workflows. Delegate intelligently. Protect your boundaries. And remember: sustainable growth beats burnout every time.

The opportunity is real. The demand is there. The question is: how will you build this practice in a way that energizes you instead of draining you?

Frequently Asked Questions

Can psychiatrists legally prescribe GLP-1 medications for weight loss?

Yes. Psychiatrists (MD/DO) have full prescriptive authority for GLP-1s in all states. These medications are not controlled substances, so there are no special restrictions. You must be licensed in the patient’s state and meet the standard of care.

Do I need to see patients in-person before prescribing via telehealth?

No. GLP-1s are not controlled substances, so the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can establish the patient relationship entirely via video, as long as your evaluation meets the standard of care (comprehensive history, appropriate assessment, informed consent, etc.).

What if I’m a psychiatric nurse practitioner (PMHNP)?

Your ability to prescribe independently depends on your state’s scope of practice laws. States like New York (after 3,600 hours), California (starting 2026 with AB 890), and Illinois (after 4,000 hours + education) allow experienced NPs to practice independently. States like Texas, Pennsylvania, and Florida require ongoing physician collaboration agreements. Check your state’s NP board requirements.

Is this practice mostly cash-pay or insurance?

Mostly cash-pay. While some insurers cover GLP-1 drugs for diabetes, coverage for obesity is limited (only 13 state Medicaid programs covered them as of 2024). Most patients pay out-of-pocket for medications, and many providers charge cash for visits to avoid insurance hassles. Some hybrid models exist (cash initial consult, insurance follow-ups).

How much time do GLP-1 patients require?

Initial consult: 45-60 minutes (comprehensive evaluation, education, treatment planning). Follow-ups during dose titration: 15-30 minutes monthly for the first 3-6 months. Once stable: 15-20 minute visits every 2-3 months. With efficient workflows and delegation, you can manage a large panel without overwhelming your schedule.

What are the key compliance issues I should worry about?

• Licensure: Must be licensed in the patient’s state
• Standard of care: Adequate evaluation, informed consent, contraindication screening, appropriate monitoring
• Documentation: Thorough charting of each encounter, especially off-label use
• Pharmacy compliance: If using compounded medications, ensure your pharmacy is FDA-compliant
• Malpractice coverage: Inform your insurer about offering weight-loss services

Can I just add this to my existing psychiatric practice, or do I need a separate business?

Most psychiatrists integrate GLP-1 services into their existing practice. You’re simply expanding your scope to include medical weight management. No separate entity needed, though you may want separate scheduling blocks or marketing materials to differentiate the service.

What if a patient has psychiatric side effects from GLP-1s?

This is where your expertise shines. Early reports suggested possible mood changes or suicidal ideation, though FDA reviews found no clear causal link and directed removal of suicide warnings from labels (early 2026). Regardless, monitor mental health closely at each visit. Ask about mood, anxiety, and suicidal thoughts. If concerns arise, you’re uniquely qualified to manage them — adjust doses, add/modify psychiatric meds, provide crisis support.

How do I market this service if I’m not on a platform?

• Update your website with GLP-1/weight management content (SEO for ‘psychiatrist weight loss [your city]’)
• Social media posts about the mental health benefits of weight loss
• Email existing patients about the new service
• Network with PCPs, therapists, dietitians for referrals
• Consider Google Ads (budget $500-1,000/month minimum; expect $200-400 per booked patient)
• List on directories (Psychology Today, Zocdoc, specialty obesity directories)

Remember: DIY marketing takes time and money. A platform like Klarity removes that burden.

What’s the biggest mistake psychiatrists make when starting GLP-1 services?

Scaling too fast without systems in place. You get overwhelmed with demand, burn out from inefficient workflows, and patient care suffers. Start small (5-10 patients), refine your intake process and protocols, delegate tasks, then grow gradually. Sustainable beats fast.

Citations

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage), May 27, 2025. Available at: www.axios.com

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry,’ October 20, 2025. Available at: www.confectionerynews.com

3. Time – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny,’ August 22, 2025. Available at: time.com

4. Axios – ‘America’s doctors need more obesity medicine training,’ May 28, 2024. Available at: www.axios.com

5. Axios – ‘States slow to cover GLP-1s for weight loss,’ November 5, 2024. Available at: www.axios.com

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is